Cargando…

Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic Cancer

SIMPLE SUMMARY: As pancreatic cancer is a disease with a high fatality rate, a better understanding of how it develops and the identification of new potential targets for its treatment are greatly needed. In this current study, we showed that the expression of amyloid precursor-like protein 2 (APLP2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poelaert, Brittany J., Knoche, Shelby M., Larson, Alaina C., Pandey, Poomy, Seshacharyulu, Parthasarathy, Khan, Nuzhat, Maurer, H. Carlo, Olive, Kenneth P., Sheinin, Yuri, Ahmad, Rizwan, Singh, Amar B., Batra, Surinder K., Rachagani, Satyanarayana, Solheim, Joyce C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036577/ https://www.ncbi.nlm.nih.gov/pubmed/33810510 http://dx.doi.org/10.3390/cancers13071535

Ejemplares similares

Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis
por: Pandey, Poomy, et al.
Publicado: (2014)

Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer
por: Seshacharyulu, Parthasarathy, et al.
Publicado: (2014)

MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism
por: Muniyan, Sakthivel, et al.
Publicado: (2016)

Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model
por: Mallya, Kavita, et al.
Publicado: (2020)

The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer
por: Knoche, Shelby M., et al.
Publicado: (2022)

Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells
por: Lakshmanan, Imayavaramban, et al.
Publicado: (2015)

Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer
por: Leon, Frank, et al.
Publicado: (2021)

Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer
por: Mimeault, Murielle, et al.
Publicado: (2015)

Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy
por: Rachagani, Satyanarayana, et al.
Publicado: (2012)

Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy
por: Torres, María P., et al.
Publicado: (2013)

PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia
por: Dey, Parama, et al.
Publicado: (2014)

Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting
por: Pothuraju, Ramesh, et al.
Publicado: (2018)

Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis
por: Kaushik, Garima, et al.
Publicado: (2020)

Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer
por: Jahan, Rahat, et al.
Publicado: (2019)

CXCR2 signaling regulates KRAS((G12D))-induced autocrine growth of pancreatic cancer
por: Purohit, Abhilasha, et al.
Publicado: (2016)

The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells
por: Palanivel, Chitra, et al.
Publicado: (2022)

FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis
por: Seshacharyulu, Parthasarathy, et al.
Publicado: (2019)

Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells
por: Barkeer, Srikanth, et al.
Publicado: (2018)

Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β
por: Kaushal, Jyoti B., et al.
Publicado: (2021)

Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis
por: Saxena, Sugandha, et al.
Publicado: (2017)

hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells
por: Karmakar, Saswati, et al.
Publicado: (2017)

Nicotine/Cigarette-smoke Promotes Metastasis of Pancreatic Cancer Through α7nAChR-mediated MUC4 Up-regulation
por: Momi, Navneet, et al.
Publicado: (2012)

PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells
por: Hein, Ashley L., et al.
Publicado: (2019)

Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma
por: Gunda, Venugopal, et al.
Publicado: (2022)

Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation
por: Chugh, Seema, et al.
Publicado: (2016)

Plexin-B3 Regulates Cellular Motility, Invasiveness, and Metastasis in Pancreatic Cancer
por: Saxena, Sugandha, et al.
Publicado: (2021)

Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells
por: Das, Srustidhar, et al.
Publicado: (2015)

Correction: Kaushal et al. Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β. Cancers 2021, 13, 3105
por: Kaushal, Jyoti B., et al.
Publicado: (2021)

Pathobiological Implications of MUC16 Expression in Pancreatic Cancer
por: Haridas, Dhanya, et al.
Publicado: (2011)

Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered Kras(G12D);Pdx1-Cre mouse (KC) model
por: Rachagani, Satyanarayana, et al.
Publicado: (2015)

Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma
por: Vengoji, Raghupathy, et al.
Publicado: (2021)

Amyloid precursor protein and amyloid precursor-like protein 2 in cancer
por: Pandey, Poomy, et al.
Publicado: (2016)

Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers
por: Natesh, Nagabhishek Sirpu, et al.
Publicado: (2021)

Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma
por: Vaz, Arokia Priyanka, et al.
Publicado: (2015)

Histidine Enhances the Anticancer Effect of Gemcitabine against Pancreatic Cancer via Disruption of Amino Acid Homeostasis and Oxidant—Antioxidant Balance
por: Kumar, Narendra, et al.
Publicado: (2023)

Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling
por: Seshacharyulu, Parthasarathy, et al.
Publicado: (2021)

MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells
por: Ponnusamy, Moorthy P, et al.
Publicado: (2011)

Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2018)

Gut microbiota: a non-target victim of pesticide-induced toxicity
por: Sharma, Tusha, et al.
Publicado: (2023)

MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer
por: Pai, Priya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q55j93vml9lte8c1jhjn3g3oo7